MIR8059: A Promising Protein Target for Cancer and Neurodegenerative Diseases

MIR8059: A Promising Protein Target for Cancer and Neurodegenerative Diseases

MIR8059, also known as hsa-mir-8059, is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and liver. It is a member of theheparan sulfate proteoglycan (HSPG) family, which is a type of carbohydrate proteoglycan that is found in many different cell types.

One of the unique features of MIR8059 is its ability to interact with a variety of different drugs, making it a promising drug target for researchers. For example, MIR8059 has been shown to interact with a variety of drugs that are used to treat a range of different conditions, including cancer, neurodegenerative diseases, and cardiovascular disease.

In addition to its potential as a drug target, MIR8059 has also been shown to be a valuable biomarker for a variety of different diseases. For example, studies have shown that MIR8059 levels can be elevated in the brains of individuals with certain forms of cancer, and that they can serve as a biomarker for the disease.

Another promising aspect of MIR8059 is its ability to be targeted with small molecules, which makes it an attractive target for drug development. This is because small molecules are often more effective at binding to protein targets than are large molecules like drugs, which can cause unintended side effects.

Overall, MIR8059 is a protein that has the potential to be a valuable drug target and biomarker for a variety of different diseases. Further research is needed to fully understand its role in the body and its potential as a therapeutic agent.

Protein Name: MicroRNA 8059

The "MIR8059 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR8059 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR8060 | MIR8061 | MIR8063 | MIR8064 | MIR8067 | MIR8069-1 | MIR8070 | MIR8071-1 | MIR8071-2 | MIR8072 | MIR8073 | MIR8075 | MIR8076 | MIR8078 | MIR8080 | MIR8082 | MIR8084 | MIR8085 | MIR8087 | MIR8088 | MIR8089 | MIR8485 | MIR873 | MIR874 | MIR875 | MIR876 | MIR877 | MIR885 | MIR887 | MIR888 | MIR889 | MIR890 | MIR891A | MIR891B | MIR892A | MIR892B | MIR892C | MIR9-1 | MIR9-1HG | MIR9-2 | MIR9-3 | MIR9-3HG | MIR920 | MIR921 | MIR922 | MIR924 | MIR924HG | MIR92A1 | MIR92A2 | MIR92B | MIR93 | MIR933 | MIR934 | MIR935 | MIR936 | MIR937 | MIR938 | MIR939 | MIR940 | MIR941-1 | MIR941-2 | MIR941-3 | MIR941-4 | MIR941-5 | MIR942 | MIR943 | MIR944 | MIR95 | MIR96 | MIR98 | MIR99A | MIR99AHG | MIR99B | MIRLET7 | MIRLET7A1 | MIRLET7A2 | MIRLET7A3 | MIRLET7B | MIRLET7BHG | MIRLET7C | MIRLET7D | MIRLET7E | MIRLET7F1 | MIRLET7F2 | MIRLET7G | MIRLET7I | MIS12 | MIS12 complex | MIS18A | MIS18A-AS1 | MIS18BP1 | MISFA | MISP | MISP3 | MITD1 | MITF | Mitochondrial complex I assembly complex | Mitochondrial import inner membrane translocase 23 (TIM23) complex | Mitochondrial inner membrane protease complex | Mitochondrial membrane ATP synthase